CR9073A - Coadministracion de tigeciclina y digoxin - Google Patents

Coadministracion de tigeciclina y digoxin

Info

Publication number
CR9073A
CR9073A CR9073A CR9073A CR9073A CR 9073 A CR9073 A CR 9073A CR 9073 A CR9073 A CR 9073A CR 9073 A CR9073 A CR 9073A CR 9073 A CR9073 A CR 9073A
Authority
CR
Costa Rica
Prior art keywords
digoxin
tigecicline
coadministration
tigecycline
administration
Prior art date
Application number
CR9073A
Other languages
English (en)
Inventor
G Raible Donald
Muralidharan Gopal
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CR9073A publication Critical patent/CR9073A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

La invencion se relaciona con el tratamiento de infecciones bacterianas con tigeciclina y la insuficiencia cardiaca con digoxin mediante la coadministracion a un humano que lo necesita.
CR9073A 2004-10-28 2007-04-20 Coadministracion de tigeciclina y digoxin CR9073A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62285904P 2004-10-28 2004-10-28

Publications (1)

Publication Number Publication Date
CR9073A true CR9073A (es) 2007-08-28

Family

ID=36127476

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9073A CR9073A (es) 2004-10-28 2007-04-20 Coadministracion de tigeciclina y digoxin

Country Status (18)

Country Link
US (1) US20060094668A1 (es)
EP (1) EP1804807B1 (es)
JP (1) JP2008518911A (es)
KR (1) KR20070069182A (es)
CN (1) CN101039679A (es)
AT (1) ATE415973T1 (es)
AU (1) AU2005310306A1 (es)
BR (1) BRPI0517406A (es)
CA (1) CA2582089A1 (es)
CR (1) CR9073A (es)
DE (1) DE602005011468D1 (es)
EC (1) ECSP077423A (es)
IL (1) IL182681A0 (es)
MX (1) MX2007005163A (es)
NO (1) NO20071706L (es)
RU (1) RU2007112409A (es)
WO (1) WO2006060084A2 (es)
ZA (1) ZA200703441B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101354093B1 (ko) * 2005-03-14 2014-01-24 와이어쓰 엘엘씨 티게사이클린 조성물 및 이의 제조방법
PE20070072A1 (es) * 2005-06-16 2007-02-25 Wyeth Corp Proceso de manufactura para tigeciclina como polvo reconstituible
GB2461037A (en) * 2008-06-17 2009-12-23 Elias Bouras A method of treating alopecia using a composition comprising a cardiac glycoside
WO2010017273A2 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
JP7199361B2 (ja) 2017-01-27 2023-01-05 ニューロクライン バイオサイエンシーズ，インコーポレイテッド 特定のｖｍａｔ２インヒビターを投与するための方法
AU2018335259A1 (en) 2017-09-21 2020-04-09 Neurocrine Biosciences, Inc. High dosage valbenazine formulation and compositions, methods, and kits related thereto
CN116492340A (zh) * 2017-10-10 2023-07-28 纽罗克里生物科学有限公司 施用某些vmat2抑制剂的方法

Also Published As

Publication number Publication date
IL182681A0 (en) 2007-09-20
CN101039679A (zh) 2007-09-19
US20060094668A1 (en) 2006-05-04
ZA200703441B (en) 2008-09-25
NO20071706L (no) 2007-05-24
ECSP077423A (es) 2007-05-30
EP1804807B1 (en) 2008-12-03
BRPI0517406A (pt) 2008-10-07
EP1804807A2 (en) 2007-07-11
DE602005011468D1 (de) 2009-01-15
KR20070069182A (ko) 2007-07-02
JP2008518911A (ja) 2008-06-05
MX2007005163A (es) 2007-06-26
ATE415973T1 (de) 2008-12-15
AU2005310306A1 (en) 2006-06-08
RU2007112409A (ru) 2008-12-10
CA2582089A1 (en) 2006-06-08
WO2006060084A3 (en) 2006-07-20
WO2006060084A2 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
CR9073A (es) Coadministracion de tigeciclina y digoxin
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
CL2009001099A1 (es) Uso de una muteina de interleuquina-2 humana para el tratamiento y/o prevencion de una enfermedad autoinmune.
UY29170A1 (es) Adeninas sustituidas y usos de las mismas
HRP20110969T1 (en) Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
CL2008001855A1 (es) Compuestos ciclicos condensados derivados del boro; composicion farmaceutica; y uso en el tratamiento y/o prevencion de una enfermedad infecciosa.
AR109263A2 (es) Composición que comprende moxidectina
CL2009000402A1 (es) Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras.
GT200500266A (es) Nuevos derivados de pirimidina y su uso
DK1809661T3 (da) Humant interferon-beta-mutein
NI200800176A (es) Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento de la depresión
CL2008002411A1 (es) Compuestos derivados de heterociclos de nitrogenos;composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de una enfermedad asociada con la miosina del musculo liso o la miosina no muscular, tales como hipertension, enfermedad pulmonar, glaucoma, apoplejia, enfermedades broncocontrictoras, entre otras.
ATE477805T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
CY1110182T1 (el) Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων
UY29189A1 (es) Nonadepsipeptidos acilados ii
UY28313A1 (es) Nonadepsipeptidos acilados
ATE433459T1 (de) Desoxo-nonadepsipeptide
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso
CL2007001910A1 (es) Compuestos derivados de penem; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
ECSP10010464A (es) Uso de ranolazina para el tratamiento de enfermedades cardiovasculares
DK1713438T3 (da) Medicinsk sæbe
ATE455789T1 (de) Substituierte nonadepsipeptide
EA201000864A1 (ru) Фенилоксетанильные производные
CL2008001613A1 (es) Compuestos macrociclicos; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
EA200802136A1 (ru) Лечение меланомы

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)